Advertisement
News
Advertisement

Synoptics Health Appoints Ultra Clean As U.S. Distributor For Proreveal

Tue, 06/24/2014 - 9:05am
Synoptics Health

ProRevealScientific Digital Imaging’s Synoptics Health Division, a manufacturer of innovative digital imaging systems for healthcare applications, is pleased to announce the appointment of industry leading surgical instrument cleaning firm, Ultra Clean Systems, Inc as its North American distributor of the ultrasensitive ProReveal Protein Detection Test. 

Ultra Clean Systems will distribute and support Synoptic Health’s ProReveal Protein Detection Test (a rapid and ultra-sensitive fluorescence technique that detects microgram levels of residual protein remaining on surgical instruments after the washer disinfector process) through its extensive support network across North America. This agreement will allow Sterile Services Departments (SSDs) throughout the country to assess the ProReveal technology on site and accurately discover how well their own surgical instrument decontamination processes perform.  

The ProReveal Test uses fluorescence to detect microgram amounts of protein on surgical instruments and is the only commercial test on the market which complies with new recommendations for preventing iatrogenic vCJD infections. 

ProReveal offers a highly sensitive alternative to swabbing techniques and tests the whole instrument for protein, rather than just a small, swabbed area. Taking less than 5 minutes to carry out, ProReveal generates results as a visual display of the presence (or absence) of any protein and these results can be documented and archived as proof of process cleanliness. Since the test is both visual and quantifiable, ProReveal provides confidence that decontamination processes are performing to the correct standards. 

Paul Ellwood, Synoptics Health’s CEO said: “As the demand for our unique ProReveal Test has increased throughout the U.S., Ultra Clean Systems with its infrastructure and extensive experience of surgical instrument decontamination in U.S. SSDs represents an ideal partner for supporting and maximising the growth of our revolutionary residual protein detection technology.” 

Paul continued: “We are confident that Ultra Clean Systems will help U.S. SSDs provide access to our unique ProReveal technology more easily. This will ensure decontamination processes are performing to the highest standard and keep patients safe from iatrogenic infections in many U.S. hospitals.”

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading